These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 10758949)
1. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). King SB; Kosinski AS; Guyton RA; Lembo NJ; Weintraub WS J Am Coll Cardiol; 2000 Apr; 35(5):1116-21. PubMed ID: 10758949 [TBL] [Abstract][Full Text] [Related]
2. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). Berger PB; Velianou JL; Aslanidou Vlachos H; Feit F; Jacobs AK; Faxon DP; Attubato M; Keller N; Stadius ML; Weiner BH; Williams DO; Detre KM; J Am Coll Cardiol; 2001 Nov; 38(5):1440-9. PubMed ID: 11691521 [TBL] [Abstract][Full Text] [Related]
3. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group. Cowley MJ; Vandermael M; Topol EJ; Whitlow PL; Dean LS; Bulle TM; Ellis SG J Am Coll Cardiol; 1993 Nov; 22(5):1289-97. PubMed ID: 8227782 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery. Zhao XQ; Brown BG; Stewart DK; Hillger LA; Barnhart HX; Kosinski AS; Weintraub WS; King SB Circulation; 1996 Jun; 93(11):1954-62. PubMed ID: 8640968 [TBL] [Abstract][Full Text] [Related]
5. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group. Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041 [TBL] [Abstract][Full Text] [Related]
6. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. BARI Investigators J Am Coll Cardiol; 2000 Apr; 35(5):1122-9. PubMed ID: 10758950 [TBL] [Abstract][Full Text] [Related]
7. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. Hueb WA; Bellotti G; de Oliveira SA; Arie S; de Albuquerque CP; Jatene AD; Pileggi F J Am Coll Cardiol; 1995 Dec; 26(7):1600-5. PubMed ID: 7594092 [TBL] [Abstract][Full Text] [Related]
8. Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease. Greenbaum AB; Califf RM; Jones RH; Gardner LH; Phillips HR; Sketch MH; Stack RS; Puma JA Am J Cardiol; 2000 Dec; 86(12):1322-6. PubMed ID: 11113406 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). Weintraub WS; Mauldin PD; Becker E; Kosinski AS; King SB Circulation; 1995 Nov; 92(10):2831-40. PubMed ID: 7586249 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST]). Alazraki NP; Krawczynska EG; Kosinski AS; DePuey EG; Ziffer JA; Taylor AT; Pettigrew RI; Vansant JP; Shaw LJ; Weintraub WS; King SB Am J Cardiol; 1999 Dec; 84(12):1369-74. PubMed ID: 10606106 [TBL] [Abstract][Full Text] [Related]
11. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). Rodriguez A; Mele E; Peyregne E; Bullon F; Perez-Baliño N; Liprandi MI; Palacios IF J Am Coll Cardiol; 1996 Apr; 27(5):1178-84. PubMed ID: 8609339 [TBL] [Abstract][Full Text] [Related]
12. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction < or = 40%. O'Keefe JH; Allan JJ; McCallister BD; McConahay DR; Vacek JL; Piehler JM; Ligon R; Hartzler GO Am J Cardiol; 1993 Apr; 71(11):897-901. PubMed ID: 8465778 [TBL] [Abstract][Full Text] [Related]
13. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). Bourassa MG; Kip KE; Jacobs AK; Jones RH; Sopko G; Rosen AD; Sharaf BL; Schwartz L; Chaitman BR; Alderman EL; Holmes DR; Roubin GS; Detre KM; Frye RL J Am Coll Cardiol; 1999 May; 33(6):1627-36. PubMed ID: 10334434 [TBL] [Abstract][Full Text] [Related]
14. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). King SB; Lembo NJ; Weintraub WS; Kosinski AS; Barnhart HX; Kutner MH; Alazraki NP; Guyton RA; Zhao XQ N Engl J Med; 1994 Oct; 331(16):1044-50. PubMed ID: 8090163 [TBL] [Abstract][Full Text] [Related]
15. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease. Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974 [TBL] [Abstract][Full Text] [Related]
16. The final 10-year follow-up results from the BARI randomized trial. BARI Investigators J Am Coll Cardiol; 2007 Apr; 49(15):1600-1606. PubMed ID: 17433949 [TBL] [Abstract][Full Text] [Related]
17. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. Niles NW; McGrath PD; Malenka D; Quinton H; Wennberg D; Shubrooks SJ; Tryzelaar JF; Clough R; Hearne MJ; Hernandez F; Watkins MW; O'Connor GT; J Am Coll Cardiol; 2001 Mar; 37(4):1008-15. PubMed ID: 11263600 [TBL] [Abstract][Full Text] [Related]
18. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. King SB; Barnhart HX; Kosinski AS; Weintraub WS; Lembo NJ; Petersen JY; Douglas JS; Jones EL; Craver JM; Guyton RA; Morris DC; Liberman HA Am J Cardiol; 1997 Jun; 79(11):1453-9. PubMed ID: 9185632 [TBL] [Abstract][Full Text] [Related]
19. Directional atherectomy versus balloon angioplasty for coronary ostial and nonostial left anterior descending coronary artery lesions: results from a randomized multicenter trial. The CAVEAT-I investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. Boehrer JD; Ellis SG; Pieper K; Holmes DR; Keeler GP; Debowey D; Chapekis AT; Leya F; Mooney MR; Gottlieb RS J Am Coll Cardiol; 1995 May; 25(6):1380-6. PubMed ID: 7722137 [TBL] [Abstract][Full Text] [Related]
20. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. Bypass Angioplasty Revascularization Investigation (BARI) Investigators N Engl J Med; 1996 Jul; 335(4):217-25. PubMed ID: 8657237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]